It’s the start of a new season and I would like to put on record the team that will start this season. Very similar to last quarter with the exception of replacing Ascendas Reit with CapitaRetail China Trust in the first team. I also drafted in Frasers Centrepoint Trust into the first eleven as I believe it will do relatively better in 2021.

The first team makes up about 70% of the portfolio. Remaining 20% are made up by the reserves, with the youth team taking up 10%. Added two counters in the last week of December as they may turnaround in 2021. I will treat them as on-loan players and will deliberate along the season before deciding if I want to add them to the team permanently.
Reserves | Youth Team and Loan |
(D) Ascendas Reit | SaaS (4.2%) |
(D) Keppel DC Reit | MFRS2020 (5.2%) |
(D) SGX | (D) Jardine Cycle & Carriage (Loan) |
(D) UMS | (M) Lumen Technologies (Loan) |
(M) Raffles Medical Group | |
(M) Microsoft | |
(M) Tractor Supply | |
(F) AEM | |
(F) Mercadolibre | |
(F) Netflix |
Target for the year remains unchanged. At least 8% return with a stretched goal of at least 12%. Projected dividend is around 19k but hopefully it can hit 20k.
Allow me to be a soccer commentator. Good team, many star players that other teams would want to buy if the price is right. Just my thoughts and hope to hear yours. I thought UMS would be a midfielder rather than a defender. It could even be a winger. Raffles Medical however looks slow but steady – showing the right qualities for a defender. How about making the swop?
The positions depend on my intent when I bought them. So I bought UMS for its consistent dividend and you are right, I will probably play him as winger (similar role to micromechanics and venture). As for raffles, bought it for its expansion into China. So it is a long term growth story. Can prob be a defensive midfielder.
Agree that RMG is not an attacking mid š. Good luck. I miss the RMG rally
Still a laggard in my portfolio. I have it for many many years liao. Hopefully the day will come for it to blossom.